SMA prenatal diagnosis: a modified protocol to help differentiation between deletions and gene conversion

Area of Science:

• Genetics
• Molecular Biology
• Neurology

Background:

• Spinal muscular atrophy (SMA) is a severe genetic neuromuscular disorder caused by mutations in the Survival Motor Neuron 1 (SMN1) gene.
• Genetic testing for SMA typically involves analyzing SMN1 gene deletions, particularly of exons 7 and 8.
• Complex SMN1 deletion patterns can pose diagnostic challenges, especially in prenatal settings.

Observation:

• The study observed atypical SMN1 gene deletions, specifically deletions limited to exon 8, which can be mistaken for homozygous deletions of exons 7-8 within a family.
• These unusual findings can obscure the accurate diagnosis of SMA during genetic screening.
• Prenatal diagnosis requires precise identification of the genetic event.

Findings:

• A modified Polymerase Chain Reaction (PCR) procedure was developed and applied.
• This modified PCR method successfully distinguished between a true SMN1 gene deletion and a gene conversion event.
• The technique proved effective in a challenging case of prenatal diagnosis involving ambiguous SMN1 deletion patterns.

Implications:

• Accurate prenatal diagnosis of SMA is crucial for genetic counseling and family planning.
• The developed modified PCR procedure offers a reliable method to resolve diagnostic ambiguities related to SMN1 gene deletions.
• This advancement can improve the accuracy of SMA genetic testing, particularly in complex or unusual cases.